Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eu Jeong Ku

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|March 19, 2021
Author replyEu Jeong Ku, Hyung Jin Choi
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 27, 2023
Long-Term Effectiveness of Quadruple Combination Therapy with Empagliflozin Versus Basal Long-Acting Insulin Therapy in Patients with Type 2 Diabetes: 3-Year Retrospective Observational StudyEu Jeong Ku, Tae Keun Oh
Nuklearmedizin. Nuclear Medicine|October 6, 2023
Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CTHansol Moon, Eu Jeong Ku, Chulhan Kim
Endocrinology and Metabolism (Seoul, Korea)|August 8, 2023
Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association GuidelinesEu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
Diabetes Research and Clinical Practice|May 29, 2018
Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose controlHyun Jeong Jeon, Eu Jeong Ku, Tae Keun Oh
Diabetes, Obesity & Metabolism|July 25, 2018
Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practiceEu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, et al.
Experimental & Molecular Medicine|January 4, 2023
Grave-to-cradle: human embryonic lineage tracing from the postmortem bodySeock Hwan Choi, Eu Jeong Ku, Yujin Angelina Choi, et al.
Journal of Korean Medical Science|April 25, 2018
Association of Adiponectin 45T/G Polymorphism with Diabetic Cardiovascular Complications in Korean Type 2 DiabetesMyeong Jin Ji, Eu Jeong Ku, Tae Keun Oh, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 13, 2023
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive ReviewWon Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, et al.
Diabetes Research and Clinical Practice|April 8, 2019
Empagliflozin versus dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin, glimepiride and dipeptidyl peptide 4 inhibitors: A 52-week prospective observational studyEu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|March 19, 2021
Author replyEu Jeong Ku, Hyung Jin Choi
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 27, 2023
Long-Term Effectiveness of Quadruple Combination Therapy with Empagliflozin Versus Basal Long-Acting Insulin Therapy in Patients with Type 2 Diabetes: 3-Year Retrospective Observational StudyEu Jeong Ku, Tae Keun Oh
Nuklearmedizin. Nuclear Medicine|October 6, 2023
Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CTHansol Moon, Eu Jeong Ku, Chulhan Kim
Endocrinology and Metabolism (Seoul, Korea)|August 8, 2023
Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association GuidelinesEu Jeong Ku, Won Sang Yoo, Hyun Kyung Chung
Diabetes Research and Clinical Practice|May 29, 2018
Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose controlHyun Jeong Jeon, Eu Jeong Ku, Tae Keun Oh
Diabetes, Obesity & Metabolism|July 25, 2018
Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glargine-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practiceEu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, et al.
Experimental & Molecular Medicine|January 4, 2023
Grave-to-cradle: human embryonic lineage tracing from the postmortem bodySeock Hwan Choi, Eu Jeong Ku, Yujin Angelina Choi, et al.
Journal of Korean Medical Science|April 25, 2018
Association of Adiponectin 45T/G Polymorphism with Diabetic Cardiovascular Complications in Korean Type 2 DiabetesMyeong Jin Ji, Eu Jeong Ku, Tae Keun Oh, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 13, 2023
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive ReviewWon Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, et al.
Diabetes Research and Clinical Practice|April 8, 2019
Empagliflozin versus dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin, glimepiride and dipeptidyl peptide 4 inhibitors: A 52-week prospective observational studyEu Jeong Ku, Dong-Hwa Lee, Hyun Jeong Jeon, et al.
Pageof 8